Viewing Study NCT06435585



Ignite Creation Date: 2024-06-16 @ 11:49 AM
Last Modification Date: 2024-10-26 @ 3:30 PM
Study NCT ID: NCT06435585
Status: RECRUITING
Last Update Posted: 2024-05-30
First Post: 2024-05-20

Brief Title: Responders and Non-responders in the Management of Heart Failure - Significance of Genetic Influence and Identification of Novel Informative Biomarkers
Sponsor: Karolinska University Hospital
Organization: Karolinska University Hospital

Study Overview

Official Title: Responders and Non-responders in the Management of Heart Failure - Significance of Genetic Influence and Identification of Novel Informative Biomarkers
Status: RECRUITING
Status Verified Date: 2024-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: Responders
Brief Summary: A biobank within the Swedish national heart failure quality registry SwedeHF
Detailed Description: The national heart failure quality registry SwedeHF started in 2003 It is the worlds largest continuous HF registry enrolling clinician-judged HF regardless of LVEF at time of hospital or clinical visit Eighty variables are entered into an electronic database managed by the Uppsala Clinical Research Center UCR There are 140000 registrations from 110000 unique patients from 70 hospitals in Sweden

University hospitals in Sweden with access to central biobanking will collect a high-quality biobank linked to SwedeHF consisting of blood plasma whole blood and urine enabling genetic proteomic and metabolomic analyses as well as analyses of different biomarkers of interest for HF patients This will provide unique opportunities for future research within the national SwedeHF registry

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None